The present disclosure relates generally to compositions and methods for preparing molded regenerated silk geometries using temperature control and mechanical processing.
Researchers have used various approaches to form regenerated silk fibers. One common technique is wet spinning. In this process, a polymer is dissolved or chemically treated into a soluble form that can be extruded through a spinneret into a wet bath. Methanol and ethanol has been used, but can cause rapid conformation changes from random coil to beta sheet, which prevents molecular chains from adjusting/aligning and limits mechanical performance improvement (Yan, J., Zhou, G., Knight, D. P., Shao, Z., and Chen, X., Wet-Spinning of Regenerated Silk Fiber from Aqueous Silk Fibroin Solution: Discussion of Spinning Parameters, Biomaterials (2010), 11, pp. 1-5). The crystalline structures formed are not well-aligned in the fiber direction and molecular chain entanglements lead to poor mechanical properties. Yan et al. utilized a coagulation bath with ammonium sulfate for wet spinning. Their simplified industrial processing equipment, which incorporated continuous mechanical post-drawing, produced fibers that rivaled the strength and toughness of natural silk cocoon fibers. The best reported properties using this process were strength of 390 MPa and over 30% strain to failure (Yan, J., Zhou, G., Knight, D. P., Shao, Z., and Chen, X., Wet-Spinning of Regenerated Silk Fiber from Aqueous Silk Fibroin Solution: Discussion of Spinning Parameters, Biomaterials (2010), 11, pp. 1-5). Zhu et al. wet spun regenerated silk fibers through a stainless steel spinneret into a methanol and acetic acid coagulation bath. After soaking for several hours, the fibers were mechanically stretched. Fibers with about 100 micron diameter demonstrated strengths of 210 MPa, about half that of native silk fiber (Zhu, Z., Imada, T., and Asakura, T., Preparation and characterization of regenerated fiber from the aqueous solution of Bombyx mori cocoon silk fibroin, Materials Chemistry and Physics (2009), 117, pp. 430-433).
Plaza et al. (Effect of Water on Bombyx mori Regenerated Silk Fibers and Its Application in Modifying Their Mechanical Properties, J of Applied Polymer Science (2008), 109, pp. 1793-1801) compared mechanical properties of natural fibers to regenerated silkworm fiber in various solvents. Both silkworm and spider fibers become compliant when immersed in water. This is attributed to two competing effects: (a) the breaking of intermolecular hydrogen bonds due to water and increased mobility of the polymer chains due to the weakened intermolecular interactions; and (b) swelling due to the inclusion of water molecules along the polymer chains. Spider silks supercontract more than 50% of original length when tested in water. Silkworm silk fibers contract less than 5% with a small decrease in properties compared to spider silk. The contraction of silk is likely due to weakening of intermolecular interactions and/or swelling of the fiber due to the inclusion of water molecules with the polymer water. It was also demonstrated that water could predictably modify the properties of regenerated silk fibers. Their regenerated silk fibers were produced by wet-spinning through a 100 micron spinneret into an ethanol bath. The regenerated fibers had voids that were left by the solvent used during coagulation. The voids were seen to collapse when the fiber was dried and to elongate with drawing (Plaza, G. R., Corsini, P., Perez-Rigueiro, J., Marsano, E., Guinea, G., and Elices, M., Effect of Water on Bombyx mori Regenerated Silk Fibers and Its Application in Modifying Their Mechanical Properties, J of Applied Polymer Science (2008), 109, pp. 1793-1801).
Mandal et al. (Biospinning by silkworms: Silk fiber matrices for tissue engineering applications, Acta Biomaterialia (2010), 6, pp. 360-371) compiled a list of tensile strengths for various fibers. Bave silk fiber generated from Bombyx Mori silkworms were reported to have tensile strength of 500 MPa with intact sericin coating and 740 MPa for degummed bave silk. Spider silks are reported to have tensile strength between 875-972 MPa. Kevlar is reported to have a very high tensile strength of 3600 MPa (Mandal B. B. and Kundu, S. C., Biospinning by silkworms: Silk fiber matrices for tissue engineering applications, Acta Biomaterialia (2010), 6, pp. 360-371). Xia et al. (Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber, Proc of the National Academy of Sciences (2010), 107, pp. 14059-14063) expressed recombinant silk proteins modeled on major spidroin I of the spider Nephila clavipes. The molecular weight was adjusted through a multimerization process. The recombinant silk proteins were dissolved in hexafluoroisopropanol (HFIP) and spun at a silk concentration of 20% (w/v). Each fiber was then hand-drawn to 5 times the original length. Tenacity (maximum fiber stress) was 508 MPa and elongation was 15%, which is somewhat close to properties for native N. clavipes dragline silk (740-1200 MPa and 18-27% elongation). It is commonly thought that mechanical properties of a polymer increase with increasing molecular weight, to a point. There may also be a threshold necessary to achieve the incredible mechanical properties exhibited by spider silk (X., X.-X., Oian, Z.-G., Ki, C. S., Park, Y. H., Kaplan, D. L., and Lee, S. Y., Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber, Proc of the National Academy of Sciences (2010), 107, pp. 14059-14063).
Regenerated silk solution can be processed in a variety of ways to create a wide array of geometries. Because of this flexibility, many applications have been explored by researchers. High-frequency sonication has been used to create silk gel that can be used for cell encapsulation (Wang, X., Kluge, J. A., Leisk, G. G., and Kaplan, D. L., Sonication-Induced Gelation of Silk Fibroin for Cell Encapsulation, Biomaterials (2008), 29, pp. 1054-1064). Through the use of high-voltage charging of a silk solution, electro spinning has been used to make nano-fiber-based tubular constructs for vascular graft tissue engineering (Soffer, L., Wang, X., Zhang, X., Kluge, J., Dorfmann, L., Kaplan, D. L., and Leisk, G., Silk-Based Electrospun Tubular Scaffolds for Tissue-Engineered Vascular Grafts, J Biomaterials Science Polymer Edition (2008), 19, pp. 653-664). Three-dimensional bone scaffolds have been created from an aqueous-based silk processing approach (Kim, H. J., Kim, U.-J., Leisk, G. G., Bayan, C., Georgakoudi, I., and Kaplan, D. L., Bone Regeneration on Macroporous Aqueous-Derived Silk 3-D Scaffolds, Macromolecular Bioscience (2007), 7, pp. 643-655). In general, demanding applications that required excellent mechanical properties, such as high stiffness and strength, and good toughness have been a challenge for the introduction of silk materials. While some post solution-processing approaches, such as water annealing and methanol treatment can provide an improvement in silk performance, there have heretofore been limitations in the level of mechanical performance possible. In general, regenerated silk solution-based geometries have not been able to achieve mechanical properties approaching the native cocoon fiber properties.
Thus, there is need in the art for compositions and methods for fabricating article from silk having enhanced mechanical properties.
Provided herein is method for fabricating or molding a variety of articles from silk. The method generally comprises pouring a silk solution in a mold and inducing a conformation change in the silk fibroin in the solution by holding the mold comprising the silk solution at room temperature or a lower temperature. In some embodiments, conformational change can be induced at a temperature from about −8° C. to about −10° C.
Without limitations any type of silk can be used for the molding process. In addition, the silk solution can be preprocessed before molding. Alternatively, or in addition, the article can be post-processed after fabrication. Articles fabricated by the method described herein can include fibers, foams, sponges, films, coatings, layers, gels, mats, meshes, hydrogels, 3D-scaffolds, controlled drug delivery systems, and the like.
Embodiments of the method described herein are based on the inventors' discovery that a silk solution undergoes conformational change at low temperatures. The microstructure of silk solution is dominated by random coil molecular conformation. It is known that the conformation can become more crystalline, achieving a higher-order conformation through several methods: time-driven self-assembly, increased temperature, decreased pH, through addition of ions, shearing, and several other ways. The most crystalline state, beta-sheet rich Silk II, provides robust mechanical strength performance, with limited elongation. Silk I conformations are typically meta-stable phases in that the material can be driven to either a more random conformation or to a more stable conformation, such as a beta-sheet conformation. Given the meta-stable behavior, significant elongation is possible, although the mechanical strength characteristics in the silk I conformation is limited. The inventors have discovered that a meta-stable phase can be achieved (likely silk I) in a silk solution that has been maintained at a low temperature. At the temperatures used, the water can begin to freeze, but the silk fibroin can still maintains some mobility. The resulting concentrating effect (molecular chains of the silk protein being collected in regions of mobility) can lead to some hydrogen bonding of chains, but not the more crystalline silk II conformation (as long as the temperature is not too cold, the time too long, etc.). The inventors have also discovered that the meta-stable form can be mechanically drawn at elevated temperature to silk material having properties which are different from silk material molded using methods presently known in the art.
Accordingly, provided herein are methods for fabricating various articles from silk using temperature control. In general, the method comprises molding a silk solution in a mold and inducing a conformation change, e.g., inducing a meta-stable phase, in the silk solution by holding the mold comprising the silk solution at room temperature or a lower temperature. Without limitations any type of silk can be used for the molding process. In addition, the silk solution can be preprocessed before molding. Alternatively, or in addition, the article can be post-processed after fabrication. Articles fabricated by the method described herein can include fibers, films, foams, sponges, coatings, layers, gels, mats, meshes, hydrogels, 3D-scaffolds, controlled drug delivery systems, and the like.
After pouring the silk solution in the mold, the mold can be held at room temperature or a lower temperature for a desired period time. For example, the mold comprising the silk solution can be held at a temperature from about −30° C. to about room temperature. In some embodiments, the mold comprising the silk solution can be held at a temperature from about −25° C. to about 20° C., from about −20° C. to about 15° C., −15° C. to about 10° C., or from about −10° C. to about 5° C. In some embodiments, the mold comprising the silk solution can be held at a temperature of about −30° C., about −25° C., about −20° C., about −15° C., about −10° C., about −5° C., about 0° C., about 5° C., about 10° C., about 15° C., about 20° C., or about 23° C. In some embodiments, the mold comprising the silk solution can be held at a temperature of about −8° C. to about −10° C.
As used herein, the term “room temperature” means a temperature of about 20° C. to about 23° C. with an average of 23° C.
Inventors have discovered that tensile strain of a fiber molded at low temperature (i.e., molded at temperature below 0° C., e.g., molded at −5° C., at −6° C., at −7° C., at −8° C., at −9° C., at −10° C., at −11° C., at −12° C., at −13° C., at −14° C., at −15° C., at −16° C., at −17° C., at −18° C., at −19° C., or at −20° C. or below) is higher than that of a fiber molded at room temperature or from a preprocessed silk solution. As used herein, the term “tensile strain” refers to the elongation of a material which is subject to tensile stress. The term “tensile stress” refers to the maximum stress that a material can withstand while being stretched or pulled before necking, which is when the material's cross-section starts to significantly contract. Typically, stress strain testing involves taking a small sample with a fixed cross-section area, and then pulling it with a controlled, gradually increasing force until the sample changes shape or breaks.
A fiber molded at low temperature can have a tensile strain from about 30% to about 70%. The tensile strain can be at a tensile stress of about 120 MPa to about 150 MPa. For example, a fiber molded at low temperature can have a tensile strain of about 30%, about 32%, about 34%, about 35%, about 40%, about 45%, about 50%, about 55%, about 65%, about 67%, or about 70%.
A fiber molded at room temperature or from a preprocessed silk solution can have a tensile strength from about 1% to about 25%. The tensile stress can be at about 90 MPa to about 180 MPa. For example, a fiber molded at room temperature or from a preprocessed silk solution can have a tensile strength about 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, 10%, 10.5%, 11%, 11.5%, 12%, 12.5%, 13%, 13.5%, 14%, 14.5%, 15%, 15.5%, 16%, 16.5%, 17%, 17.5%, 18%, 18.5%, 19%, 19.5%, 20%, 20.5%, 21%, 21.5%, 22%, 22.5%, 23%, 23.5%, 24%, 24.5% or 25%.
The mold comprising the silk solution can be kept at the holding temperature for any period of time. One of skill in the art can determine the optimum time based on the concentration of the silk solution used, desired degree of conformational change, desired mechanical properties of the molded article, desired viscosity of the silk solution in the mold, type of post-processing, and the like. Accordingly, the mold comprising the silk solution can be kept at the holding temperature for about 1 hour to about 6 months. In some embodiments, the mold comprising the silk solution can be kept at the holding temperature for at least one day, two days, three days, four days, five days, six days, one week, two weeks, three weeks, four weeks, one month, two months, three months, four months, five months or more. The preferred times for maintaining the molds at low temperature is 5-6 days, depending on the volume and concentration of silk solution utilized (longer times are preferred with larger volume).
Without limitations, the fabricated article can comprise a silk II beta-sheet crystallinity content of at least about 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 3%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least about 95% but not 100% (i.e., all the silk is present in a silk II beta-sheet conformation). In some embodiments, the silk in the fabricated article can be present completely in a silk II beta-sheet conformation.
The fabricated article can be removed from the mold using methods and process well known in the art and available to an ordinarily skilled artisan. For example, the mold can be warmed to room temperature and the fabricated article removed from the mold. In one example, when the mold is a tube, the fabricated article, i.e., a fiber, can be removed from the mold by pushing an aqueous solution, e.g., water (milliQ water), from one end of the tube to extrude the fiber from the tube.
Silk solution can have any concentration of silk fibroins for the molding process. Generally, a higher concentration needs a shorter time for inducing a conformational change at room temperature or a lower temperature. Accordingly, the silk solution for molding can have a silk fibroin concentration of from about 1% to about 50%. In some embodiments, the silk fibroin solution has a silk fibroin concentration of from about 10% to about 40% or from 15% to about 35%. In one embodiment, the silk fibroin solution has a silk fibroin concentration of from about 20% to about 30%. In one embodiment, the silk fibroin solution has a silk fibroin concentration of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, or about 45%.
As used herein, the term “fibroin” includes silkworm fibroin and insect or spider silk protein (Lucas et al., Adv. Protein Chem 13: 107-242 (1958)). Preferably, fibroin is obtained from a solution containing a dissolved silkworm silk or spider silk. The silkworm silk protein is obtained, for example, from Bombyx mori, and the spider silk is obtained from Nephila clavipes. In the alternative, the silk proteins suitable for use according to the present disclosure can be obtained from a solution containing a genetically engineered silk, such as from bacteria, yeast, mammalian cells, transgenic animals or transgenic plants. See, for example, WO 97/08315 and U.S. Pat. No. 5,245,012, content of both of which is incorporated herein by reference.
The silk fibroin solution can be prepared by any conventional method known to one skilled in the art. For example, B. mori cocoons are boiled for about 30 minutes in an aqueous solution. Preferably, the aqueous solution is about 0.02M Na2CO3. The cocoons are rinsed, for example, with water to extract the sericin proteins and the extracted silk is dissolved in an aqueous salt solution. Salts useful for this purpose include lithium bromide, lithium thiocyanate, calcium nitrate or other chemicals capable of solubilizing silk. Preferably, the extracted silk is dissolved in about 9-12 M LiBr solution. The salt is consequently removed using, for example, dialysis or chromatography.
If necessary, the solution can then be concentrated using, for example, dialysis against a hygroscopic polymer, for example, PEG, a polyethylene oxide, amylose or sericin. Preferably, the PEG is of a molecular weight of 8,000-10,000 g/mol and has a concentration of 10-50%. A slide-a-lyzer dialysis cassette (Pierce, MW CO 3500) is preferably used. However, any dialysis system may be used. The dialysis is for a time period sufficient to result in a final concentration of aqueous silk solution between 10-30%. In most cases dialysis for 2-12 hours is sufficient. See, for example, PCT application PCT/US/04/11199, content of which is incorporated herein by reference.
Alternatively, the silk fibroin solution can be produced using organic solvents. Such methods have been described, for example, in Li, M., et al., J. Appl. Poly Sci. 2001, 79, 2192-2199; Min, S., et al. Sen'I Gakkaishi 1997, 54, 85-92; Nazarov, R. et al., Biomacromolecules 2004 May-June; 5(3):718-26.
The silk fibroin for molding can be modified for different applications or desired mechanical or chemical properties of the fabricated article. One of skill in the art can select appropriate methods to modify silk fibroins, e.g., depending on the side groups of the silk fibroins, desired reactivity of the silk fibroin and/or desired charge density on the silk fibroin. In one embodiment, modification of silk fibroin can use the amino acid side chain chemistry, such as chemical modifications through covalent bonding, or modifications through charge-charge interaction. Exemplary chemical modification methods include, but are not limited to, carbodiimide coupling reaction (see, e.g. U.S. Patent Application. No. US 2007/0212730), diazonium coupling reaction (see, e.g., U.S. Patent Application No. US 2009/0232963), avidin-biotin interaction (see, e.g., International Application No.: WO 2011/011347) and pegylation with a chemically active or activated derivatives of the PEG polymer (see, e.g., International Application No. WO 2010/057142). Silk fibroin can also be modified through gene modification to alter functionalities of the silk protein (see, e.g., International Application No. WO 2011/006133). For instance, the silk fibroin can be genetically modified, which can provide for further modification of the silk such as the inclusion of a fusion polypeptide comprising a fibrous protein domain and a mineralization domain, which can be used to form an organic-inorganic composite. See WO 2006/076711. In some embodiments, the silk fibroin can be genetically modified to be fused with a protein, e.g., a therapeutic protein. Additionally, the silk fibroin matrix can be combined with a chemical, such as glycerol, that, e.g., affects flexibility and/or solubility of the matrix. See, e.g., WO 2010/042798, Modified Silk films Containing Glycerol.
Before pouring into the mold, the silk solution can be preprocessed. For example, the silk solution can be subjected to an electogelation step to form a silk electrogel (egel). The formed egel can be removed from the solution and the remaining solution used for molding. Silk electrogelation (egel) is a processing modality for silk fibroin protein. In simple terms, the egel process applies an electric field (either direct or alternating current, referred to as DC or AC) to solubilized silk fibroin solution, causing a transformation of the silk protein's random coil conformation into a meta-stable, silk I conformation. The electric field can be applied through using a voltage source, such as a DC or AC voltage source. Direct current is produced by sources such as batteries, thermocouples, solar cells, etc. Alternatively, alternating current (AC), the general powder source for business and residence, can also be used to induce the electrogelation process, although the gel formation may not be as fast as the gelation process induced by direct current voltage. Other methods of applying an electric field to the silk solution can also be used, such as current sources, antennas, lasers, and other generators. The resulting gel-like substance has a very sticky, thick, mucus-like consistency and has many interesting properties, including muco-adhesive qualities and the ability to be further transformed into other conformations, including back to a random coil conformation or to an even higher-order β-sheet conformation. The method of eletrogelation, the related parameters used in the eletrogelation process and the structural transition of silk fibroin during the electrogelation process can be found, for example, in WO/2010/036992, content of which is incorporated herein by reference. One can also use the egel portion for molding an article according to the method described herein. For example, the egel portion can be heated before pouring into the mold. Without wishing to be bound by a theory, the egel viscosity is decreased by heating. When egel is heated, the viscosity decreases, but the original material properties return when the egel cools back to room temperature.
In some embodiments, the silk solution to be used for molding can be preprocessed at room temperature or a lower temperature for a period time before pouring into the mold. Without wishing to be bound by a theory, when the silk solution is preprocessed, self-assembly into beta-sheet conformation can begin before the molding process. This can increase the beta-sheet content of the solution to be used for the molding. Molding such a silk solution at room temperature or a lower temperature accelerates the assembly process and further increases the beta-sheet content. The material can be removed from the mold before the silk is completely solid, producing a rubbery material that has high water content. The inventors have discovered that such pretreatment can enhance properties, such as mechanical properties, and allows use of higher temperature (e.g. room temperature) or shorter molding times for the molding process. This can be beneficial if the molded article comprises a temperature or time-sensitive material.
The silk solution to be used for molding can comprise one or more (e.g., one, two, three, four, five or more) additives in addition to the silk fibroins. Without limitations, an additive can be selected from small organic or inorganic molecules; saccharines; oligosaccharides; polysaccharides; biological macromolecules, e.g., peptides, proteins, and peptide analogs and derivatives; peptidomimetics; antibodies and antigen binding fragments thereof; nucleic acids; nucleic acid analogs and derivatives; glycogens or other sugars; immunogens; antigens; an extract made from biological materials such as bacteria, plants, fungi, or animal cells; animal tissues; naturally occurring or synthetic compositions; and any combinations thereof. Total amount of additives in the solution can be from about 0.1 wt % to about 70 wt %, from about 5 wt % to about 60 wt %, from about 10 wt % to about 50 wt %, from about 15 wt % to about 45 wt %, or from about 20 wt % to about 40 wt %, of the total silk fibroin in the solution.
In some embodiments, an additive is a biocompatible polymer. Exemplary biocompatible polymers include, but are not limited to, a poly-lactic acid (PLA), poly-glycolic acid (PGA), poly-lactide-co-glycolide (PLGA), polyesters, poly(ortho ester), poly(phosphazine), poly(phosphate ester), polycaprolactone, gelatin, collagen, fibronectin, keratin, polyaspartic acid, alginate, chitosan, chitin, hyaluronic acid, pectin, polyhydroxyalkanoates, dextrans, and polyanhydrides, polyethylene oxide (PEO), poly(ethylene glycol) (PEG), triblock copolymers, polylysine, alginate, polyaspartic acid, any derivatives thereof and any combinations thereof. Other exemplary biocompatible polymers amenable to use according to the present disclosure include those described for example in U.S. Pat. No. 6,302,848; No. 6,395,734; No. 6,127,143; No. 5,263,992; No. 6,379,690; No. 5,015,476; No. 4,806,355; No. 6,372,244; No. 6,310,188; No. 5,093,489; No. U.S. 387,413; No. 6,325,810; No. 6,337,198; No. U.S. Pat. No. 6,267,776; No. 5,576,881; No. 6,245,537; No. 5,902,800; and No. 5,270,419, content of all of which is incorporated herein by reference.
Other additives suitable for use with the present disclosure include biologically or pharmaceutically active compounds. Examples of biologically active compounds include, but are not limited to: cell attachment mediators, such as collagen, elastin, fibronectin, vitronectin, laminin, proteoglycans, or peptides containing known integrin binding domains e.g. “RGD” integrin binding sequence, or variations thereof, that are known to affect cellular attachment (Schaffner P & Dard 2003 Cell Mol Life Sci. January; 60(1):119-32; Hersel U. et al. 2003 Biomaterials. November; 24(24):4385-415); biologically active ligands; and substances that enhance or exclude particular varieties of cellular or tissue ingrowth. Other examples of additive agents that enhance proliferation or differentiation include, but are not limited to, osteoinductive substances, such as bone morphogenic proteins (BMP); cytokines, growth factors such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), insulin-like growth factor (IGF-I and II) TGF-β1 and the like.
In some embodiments, additive is silk powder. As used herein, the term “silk powder” refers to non-pigmentitious particles comprising silk finbroin. The particle generally have a particle size ranging from about 0.02 to 200, preferably 0.5 to 100, microns. The particulates can also be in the fiber form such as silk fibers and the like. Such fibers are generally circular in cross-section and have a discernable length. In some embodiments, total amount of silk powder in the solution can be from about 0.1 wt % to about 70 wt %, from about 5 wt % to about 60 wt %, from about 10 wt % to about 50 wt %, from about 15 wt % to about 45 wt %, or from about 20 wt % to about 40 wt %, of the total silk fibroin in the solution.
After the molded article has been removed from the mold, the article can undergoing further processing, i.e., post-processing. For example, the article can be dried, rehydrated, mechanically processed, coated, freeze-dried, applying of shear-stress, or a combination thereof.
Any process known to one of skill in the art can be used for drying the fabricated article. For example, the fabricated article can be dried using air flow, inert gas flow, heating, freeze-drying, treating with an alcohol (e.g. methanol, ethanol, etc), or a combination thereof. The alcohol concentration can be at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90% or 100%.
In some embodiments, the molded article can be coated with a composition comprising one or more natural or synthetic biocompatible or non-biocompatible polymers. Without wising to be bound by a theory, coating the molded article with one or more polymers provides enhanced properties, for example, properties for mechanical processing. Exemplary biocompatible polymers include, but are not limited to, polyethylene oxide, polyethylene glycol, collagens (native, reprocessed or genetically engineered versions), polysaccharides (native, reprocessed or genetically engineered versions, e.g. hyaluronic acid, alginates, xanthans, pectin, chitosan, chitin, and the like), elastin (native, reprocessed or genetically engineered and chemical versions), agarose, polyhydroxyalkanoates, pullan, starch (amylose amylopectin), cellulose, cotton, gelatin, fibronectin, keratin, polyaspartic acid, polylysin, alginate, chitosan, chitin, poly lactide, poly glycolic, poly(lactide-co-glycolide), poly caproloactone, polyamides, polyanhydrides, polyaminoacids, polyortho esters, poly acetals, proteins, degradable polyurethanes, polysaccharides, polycyanoacrylates, glycosamino glycans (e.g., chrondroitin sulfate, heparin, etc.), and the like. Exemplary non-biodegradable polymers include, but are not limited to, polyamide, polyester, polystyrene, polypropylene, polyacrylate, polyvinyl, polycarbonate, polytetrafluorethylene and nitrocellulose material. In some embodiments, the polymer is sericin.
The inventors have discovered that a fiber molded by a method described herein can be further processed to provide enhanced strength and toughness relative to a fiber fabricated using methods currently known in the art. Accordingly, a molded fiber can be subjected to a stretching or drawing process. The stretching process can comprise stretching the fabricated article, e.g., a fiber, from its ends. A fiber can be allowed to dry before undergoing a drawing process.
The drawing process can comprise applying lateral pressure on the fiber while drawing the fiber along its axis. The drawing process can be repeated any desired number of times to obtain a fiber of desired thickness or mechanical properties. This process of fiber drawing can mimic the native process, leading to superior outcomes to all other fiber formation processes using regenerated silk. See, e.g., Zhou et al. (Adv. Mats. 209, 21: 366-370).
The amount that each fiber can be stretched or drawn can be affected by how many drawing cycles are used, how much lateral pressure is used during the drawing process, and if and how the molded fiber is processed during or before undergoing the stretching or drawing process. Accordingly, in some embodiments, moisture can be applied to the fiber while drawing it. In addition, or alternatively, a molded fiber can be processed soaking the molded fiber in a steam, boiling water, or in oil (e.g., mineral oil) before the stretching or drawing process. Without wishing to be bound by a theory, processed fibers are more flexible after exposure to moisture, moist heat, or soaking in oil. Accordingly, additional drawing cycles can be applied to the fibers. Thus, this process can be used for increasing the amount of drawing that can be applied to fibers, without causing premature failure or significantly degrading the elongation capability of the regenerated fibers.
As discussed above, inventors' discovery that a meta-stable phase can be achieved (likely silk I) in a silk solution that has been maintained at a low temperature. Further, the inventors' have also discovered that silk in the meta-stable form can be mechanically drawn at elevated temperature to provide silk material having properties which are different from silk material molded using methods presently known in the art. Accordingly, silk in the meta-stable form can be drawn at temperatures from about 20° C. or higher, e.g., about 21° C. or higher, about 22° C. or higher, about 23° C. or higher, about 24° C. or higher, about 25° C. or higher, about 26° C. or higher, about 27° C. or higher, about 28° C. or higher, about 29° C. or higher, about 30° C. or higher, about 31° C. or higher, about 32° C. or higher, about 33° C. or higher, about 34° C. or higher, about 35° C. or higher. In some embodiments, the meta-stable form can be mechanically drawn at a temperature from about 20° C. to about 75° C., from about 20° C. to about 70° C., from about 20° C. to about 65° C., from about 20° C. to about 60° C., from about 20° C. to about 55° C., from about 20° C. to about 50° C., from about 20° C. to about 45° C., about 20° C. to about 40° C., from about 20° C. to about 35° C., or from about 20° C. to about 30° C.
The inventors have also discovered that the moist fiber stretches significantly; during stretching, a stretch limit is reached after each drawing cycle; significant decrease in diameter and increase in length can be achieved. Further, a fiber made using the method described herein shows remarkable strength and toughness relative to a fiber made using currently used methods for making silk fibers. Additionally, a fiber made using a method described herein maintains flexibility, even after many days of air drying.
The silk fiber made by the method described herein can be used for biomed applications and industrial applications. Further, since a fiber made by the method described herein can be transparent, can transmit light, such as a laser light, and therefore can be used as optical fiber.
A silk fiber produced by the process described herein can undergo further processing to obtain a desired article. For example, the fiber can be rolled to provide a strip of silk.
The silk fiber can also be contracted, such as by reducing the ambient humidity to which the silk fiber is exposed; or expanded, such as by increasing the ambient humidity to which the silk fiber is exposed. Additionally, the silk fiber can be further processed, for example with a methanol treatment, to generate water-insoluble silk fiber.
Silk fibers produced from the method of the invention can be wrapped with other type of fibers made from silk or other materials, natural or synthetic, into a fiber bundle or fiber composite. For example, a fiber composite can be made from one or more silk fibers of the invention combined with one or more native silkworm fibroin fibers to form a silk-fiber-based matrix. Immunogenic components in the silk (such as sericin) can be removed from native silk fiber if such silk fiber based matrix is to be used as implantable materials. These silk fiber based matrix can be used to produce tissue materials for surgical implantation into a compatible recipient, e.g., for replacement or repair of damaged tissue. Some non-limiting examples of tissue materials that can be produced include ligaments or tendons such as anterior cruciate ligament, posterior cruciate ligament, rotator cuff tendons, medial collateral ligament of the elbow and knee, flexor tendons of the hand, lateral ligaments of the ankle and tendons and ligaments of the jaw or temporomandibular joint; cartilage (both articular and meniscal), bone, muscle, skin and blood vessels. Methods of making tissue materials or medical device using silk-fiber based matrix or silk composite containing silk fibers may be found in, e.g., U.S. Pat. No. 6,902,932, Helically organized silk fibroin fiber bundles for matrices in tissue engineering; U.S. Pat. No. 6,287,340, Bioengineered anterior cruciate ligament; U.S. Patent Application Publication Nos. 2002/0062151, Bioengineered anterior cruciate ligament; 2004/0224406, Immunoneutral silk-fiber-based medical devices; 2005/0089552, Silk fibroin fiber bundles for matrices in tissue engineering; 20080300683, Prosthetic device and method of manufacturing the same; 2004/0219659, Multi-dimensional strain bioreactor; 2010/0209405, Sericin extracted silkworm fibroin fibers, which are incorporated by reference in their entirety.
Silk fibers produced from the method of the invention can be incorporated into textile (e.g., yarns, fabrics) and textile-based structures using traditional textile-processing equipment, including winding, twisting, flat braiding, weaving, spreading, crocheting, bonding, tubular braiding, knitting, knotting, and felting (i.e., matting, condensing or pressing) machines. Such textiles can be incorporated in composite materials and structures through many known composite-manufacturing processes.
Silk fibers produced from the method of the invention can be combined with other forms of silk material, such as silk films (WO2007/016524), coatings (WO2005/000483; WO2005/123114), microspheres (PCT/US2007/020789), layers, hydrogel (WO2005/012606; PCT/US08/65076), mats, meshes, sponges (WO2004/062697), 3-D solid blocks (WO2003/056297), etc., to form an all-silk composite. The silk composite material can be reinforced by silk fiber, as well as incorporate the optical property of silk optical fiber into the composite. For example, a one, two or three-dimensional silk composite can be prepared by exposing silk fiber with silk fibroin solution and drying or solidifying the silk fibroin solution containing the silk fiber of the invention to form the silk composite. Different solidifying processes and additional approaches for processing silk fibroin solution into different formats of silk materials can be used. See, e.g., WO/2005/012606; WO/2008/150861; WO/2006/042287; WO/2007/016524; WO 03/004254, WO 03/022319; WO 04/000915.
Moreover, silk fiber produced by the method of the invention can be combined with one or more other natural or synthetic biocompatible or non-biocompatible polymers, and incorporated into a composite with different material formats, such as fibers, films, coatings, layers, gels, mats, meshes, hydrogel, sponges, 3-D scaffold, and the like. The non-limiting biocompatible polymers include polyethylene oxide, polyethylene glycol, collagens (native, reprocessed or genetically engineered versions), polysaccharides (native, reprocessed or genetically engineered versions, e.g. hyaluronic acid, alginates, xanthans, pectin, chitosan, chitin, and the like), elastin (native, reprocessed or genetically engineered and chemical versions), agarose, polyhydroxyalkanoates, pullan, starch (amylose amylopectin), cellulose, cotton, gelatin, fibronectin, keratin, polyaspartic acid, polylysin, alginate, chitosan, chitin, poly lactide, poly glycolic, poly(lactide-co-glycolide), poly caproloactone, polyamides, polyanhydrides, polyaminoacids, polyortho esters, poly acetals, proteins, degradable polyurethanes, polysaccharides, polycyanoacrylates, glycosamino glycans (e.g., chrondroitin sulfate, heparin, etc.), and the like. Exemplary non-biodegradable polymers include polyamide, polyester, polystyrene, polypropylene, polyacrylate, polyvinyl, polycarbonate, polytetrafluorethylene and nitrocellulose material. When incorporating silk fiber into the composite, one or more of these aforementioned polymers can be combined. See also, e.g., U.S. Pat. No. 6,902,932; U.S. Patent Application Publication Nos. 2004/0224406; 2005/0089552; 2010/0209405.
The geometry and properties of composite materials containing the silk fiber of the invention can be tailored to specific applications. For example, single fiber layers have been shown to be very tough and flexible. Cylindrical mandrels can be used to produce very stiff rod or tubular constructs that can have impressive compressive, tensile, flexural, and torsional properties. Custom wavy or highly curved geometries can also be produced.
The composite material generally enhances the matrix properties such as mechanical strength, porosity, degradability, and the like, and also enhances cell seeding, proliferation, differentiation or tissue development when used as medical suture or implantable tissue materials.
Silk fibroin in the silk fiber can also be chemically modified with active agents in the solution, for example through diazonium or carbodiimide coupling reactions, avidin-biodin interaction, or gene modification and the like, to alter the physical properties and functionalities of the silk protein. See, e.g., PCT/US09/64673; PCT/US10/42502; PCT/US2010/41615; U.S. patent application Ser. No. 12/192,588.
An article molded using the method described herein can include at least one active agent. The agent can be embedded in the article or immobilized on the surface of the article. The active agent can be a therapeutic agent or biological material, such as chemicals, cells (including stem cells) or tissues, proteins, peptides, nucleic acids (e.g., DNA, RNA, siRNA), nucleic acid analogues, nucleotides, oligonucleotides or sequences, peptide nucleic acids (PNA), aptamers, antibodies or fragments or portions thereof (e.g., paratopes or complementarity-determining regions), antigens or epitopes, hormones, hormone antagonists, cell attachment mediators (such as RGD), growth factors or recombinant growth factors and fragments and variants thereof, cytokines, enzymes, antioxidants, antibiotics or antimicrobial compounds, anti-inflammation agents, antifungals, viruses, antivirals, toxins, prodrugs, drugs, dyes, amino acids, vitamins, chemotherapeutic agents, small molecules, and combinations thereof. The agent can also be a combination of any of the above-mentioned active agents.
As used herein, the term “therapeutic agent” means a molecule, group of molecules, complex or substance administered to an organism for diagnostic, therapeutic, preventative medical, or veterinary purposes. As used herein, the term “therapeutic agent” includes a “drug” or a “vaccine.” This term include externally and internally administered topical, localized and systemic human and animal pharmaceuticals, treatments, remedies, nutraceuticals, cosmeceuticals, biologicals, devices, diagnostics and contraceptives, including preparations useful in clinical and veterinary screening, prevention, prophylaxis, healing, wellness, detection, imaging, diagnosis, therapy, surgery, monitoring, cosmetics, prosthetics, forensics and the like. This term can also be used in reference to agriceutical, workplace, military, industrial and environmental therapeutics or remedies comprising selected molecules or selected nucleic acid sequences capable of recognizing cellular receptors, membrane receptors, hormone receptors, therapeutic receptors, microbes, viruses or selected targets comprising or capable of contacting plants, animals and/or humans. This term can also specifically include nucleic acids and compounds comprising nucleic acids that produce a therapeutic effect, for example deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or mixtures or combinations thereof, including, for example, DNAnanoplexes.
The term “therapeutic agent” also includes an agent that is capable of providing a local or systemic biological, physiological, or therapeutic effect in the biological system to which it is applied. For example, the therapeutic agent can act to control infection or inflammation, enhance cell growth and tissue regeneration, control tumor growth, act as an analgesic, promote anti-cell attachment, and enhance bone growth, among other functions. Other suitable therapeutic agents can include anti-viral agents, hormones, antibodies, or therapeutic proteins. Other therapeutic agents include prodrugs, which are agents that are not biologically active when administered but, upon administration to a subject are converted to biologically active agents through metabolism or some other mechanism. Additionally, a silk-based drug delivery composition can contain combinations of two or more therapeutic agents.
A therapeutic agent can include a wide variety of different compounds, including chemical compounds and mixtures of chemical compounds, e.g., small organic or inorganic molecules; saccharines; oligosaccharides; polysaccharides; biological macromolecules, e.g., peptides, proteins, and peptide analogs and derivatives; peptidomimetics; antibodies and antigen binding fragments thereof; nucleic acids; nucleic acid analogs and derivatives; an extract made from biological materials such as bacteria, plants, fungi, or animal cells; animal tissues; naturally occurring or synthetic compositions; and any combinations thereof. In some embodiments, the therapeutic agent is a small molecule.
As used herein, the term “small molecule” can refer to compounds that are “natural product-like,” however, the term “small molecule” is not limited to “natural product-like” compounds. Rather, a small molecule is typically characterized in that it contains several carbon-carbon bonds, and has a molecular weight of less than 5000 Daltons (5 kDa), preferably less than 3 kDa, still more preferably less than 2 kDa, and most preferably less than 1 kDa. In some cases it is preferred that a small molecule have a molecular weight equal to or less than 700 Daltons.
Exemplary therapeutic agents include, but are not limited to, those found in Harrison's Principles of Internal Medicine, 13th Edition, Eds. T. R. Harrison et al. McGraw-Hill N.Y., N.Y.; Physicians Desk Reference, 50th Edition, 1997, Oradell N.J., Medical Economics Co.; Pharmacological Basis of Therapeutics, 8th Edition, Goodman and Gilman, 1990; United States Pharmacopeia, The National Formulary, USP XII NF XVII, 1990, the complete contents of all of which are incorporated herein by reference.
Therapeutic agents include the herein disclosed categories and specific examples. It is not intended that the category be limited by the specific examples. Those of ordinary skill in the art will recognize also numerous other compounds that fall within the categories and that are useful according to the present disclosure. Examples include a radiosensitizer, a steroid, a xanthine, a beta-2-agonist bronchodilator, an anti-inflammatory agent, an analgesic agent, a calcium antagonist, an angiotensin-converting enzyme inhibitors, a beta-blocker, a centrally active alpha-agonist, an alpha-1-antagonist, an anticholinergic/antispasmodic agent, a vasopres sin analogue, an antiarrhythmic agent, an antiparkinsonian agent, an antiangina/antihypertensive agent, an anticoagulant agent, an antiplatelet agent, a sedative, an ansiolytic agent, a peptidic agent, a biopolymeric agent, an antineoplastic agent, a laxative, an antidiarrheal agent, an antimicrobial agent, an antifingal agent, a vaccine, a protein, or a nucleic acid. In a further aspect, the pharmaceutically active agent can be coumarin, albumin, steroids such as betamethasone, dexamethasone, methylprednisolone, prednisolone, prednisone, triamcinolone, budesonide, hydrocortisone, and pharmaceutically acceptable hydrocortisone derivatives; xanthines such as theophylline and doxophylline; beta-2-agonist bronchodilators such as salbutamol, fenterol, clenbuterol, bambuterol, salmeterol, fenoterol; antiinflammatory agents, including antiasthmatic anti-inflammatory agents, antiarthritis antiinflammatory agents, and non-steroidal antiinflammatory agents, examples of which include but are not limited to sulfides, mesalamine, budesonide, salazopyrin, diclofenac, pharmaceutically acceptable diclofenac salts, nimesulide, naproxene, acetaminophen, ibuprofen, ketoprofen and piroxicam; analgesic agents such as salicylates; calcium channel blockers such as nifedipine, amlodipine, and nicardipine; angiotensin-converting enzyme inhibitors such as captopril, benazepril hydrochloride, fosinopril sodium, trandolapril, ramipril, lisinopril, enalapril, quinapril hydrochloride, and moexipril hydrochloride; beta-blockers (i.e., beta adrenergic blocking agents) such as sotalol hydrochloride, timolol maleate, esmolol hydrochloride, carteolol, propanolol hydrochloride, betaxolol hydrochloride, penbutolol sulfate, metoprolol tartrate, metoprolol succinate, acebutolol hydrochloride, atenolol, pindolol, and bisoprolol fumarate; centrally active alpha-2-agonists such as clonidine; alpha-1-antagonists such as doxazosin and prazosin; anticholinergic/antispasmodic agents such as dicyclomine hydrochloride, scopolamine hydrobromide, glycopyrrolate, clidinium bromide, flavoxate, and oxybutynin; vasopressin analogues such as vasopressin and desmopressin; antiarrhythmic agents such as quinidine, lidocaine, tocamide hydrochloride, mexiletine hydrochloride, digoxin, verapamil hydrochloride, propafenone hydrochloride, flecamide acetate, procainamide hydrochloride, moricizine hydrochloride, and disopyramide phosphate; antiparkinsonian agents, such as dopamine, L-Dopa/Carbidopa, selegiline, dihydroergocryptine, pergolide, lisuride, apomorphine, and bromocryptine; antiangina agents and antihypertensive agents such as isosorbide mononitrate, isosorbide dinitrate, propranolol, atenolol and verapamil; anticoagulant and antiplatelet agents such as Coumadin, warfarin, acetylsalicylic acid, and ticlopidine; sedatives such as benzodiazapines and barbiturates; ansiolytic agents such as lorazepam, bromazepam, and diazepam; peptidic and biopolymeric agents such as calcitonin, leuprolide and other LHRH agonists, hirudin, cyclosporin, insulin, somatostatin, protirelin, interferon, desmopres sin, somatotropin, thymopentin, pidotimod, erythropoietin, interleukins, melatonin, granulocyte/macrophage-CSF, and heparin; antineoplastic agents such as etoposide, etoposide phosphate, cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, doxorubicin, cisplatin, hydroxyurea, leucovorin calcium, tamoxifen, flutamide, asparaginase, altretamine, mitotane, and procarbazine hydrochloride; laxatives such as senna concentrate, casanthranol, bisacodyl, and sodium picosulphate; antidiarrheal agents such as difenoxine hydrochloride, loperamide hydrochloride, furazolidone, diphenoxylate hdyrochloride, and microorganisms; vaccines such as bacterial and viral vaccines; antimicrobial agents such as penicillins, cephalosporins, and macrolides, antifungal agents such as imidazolic and triazolic derivatives; and nucleic acids such as DNA sequences encoding for biological proteins, and antisense oligonucleotides.
Exemplary antibiotics suitable for use herein include, but are not limited to, aminoglycosides (e.g., neomycin), ansamycins, carbacephem, carbapenems, cephalosporins (e.g., cefazolin, cefaclor, cefditoren, cefditoren, ceftobiprole), glycopeptides (e.g., vancomycin), macrolides (e.g., erythromycin, azithromycin), monobactams, penicillins (e.g., amoxicillin, ampicillin, cloxacillin, dicloxacillin, flucloxacillin), polypeptides (e.g., bacitracin, polymyxin B), quinolones (e.g., ciprofloxacin, enoxacin, gatifloxacin, ofloxacin, etc.), sulfonamides (e.g., sulfasalazine, trimethoprim, trimethoprim-sulfamethoxazole (co-trimoxazole)), tetracyclines (e.g., doxycyline, minocycline, tetracycline, etc.), chloramphenicol, lincomycin, clindamycin, ethambutol, mupirocin, metronidazole, pyrazinamide, thiamphenicol, rifampicin, thiamphenicl, dapsone, clofazimine, quinupristin, metronidazole, linezolid, isoniazid, fosfomycin, or fusidic acid.
Exemplary cells suitable for use herein may include, but are not limited to, progenitor cells or stem cells (e.g., bone marrow stromal cells), ligament cells, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, epithelial cells, endothelial cells, urothelial cells, fibroblasts, myoblasts, chondrocytes, chondroblasts, osteoblasts, osteoclasts, keratinocytes, hepatocytes, bile duct cells, pancreatic islet cells, thyroid, parathyroid, adrenal, hypothalamic, pituitary, ovarian, testicular, salivary gland cells, adipocytes, and precursor cells.
Exemplary antibodies include, but are not limited to, abciximab, adalimumab, alemtuzumab, basiliximab, bevacizumab, cetuximab, certolizumab pegol, daclizumab, eculizumab, efalizumab, gemtuzumab, ibritumomab tiuxetan, infliximab, muromonab-CD3, natalizumab, ofatumumab omalizumab, palivizumab, panitumumab, ranibizumab, rituximab, tositumomab, trastuzumab, altumomab pentetate, arcitumomab, atlizumab, bectumomab, belimumab, besilesomab, biciromab, canakinumab, capromab pendetide, catumaxomab, denosumab, edrecolomab, efungumab, ertumaxomab, etaracizumab, fanolesomab, fontolizumab, gemtuzumab ozogamicin, golimumab, igovomab, imciromab, labetuzumab, mepolizumab, motavizumab, nimotuzumab, nofetumomab merpentan, oregovomab, pemtumomab, pertuzumab, rovelizumab, ruplizumab, sulesomab, tacatuzumab tetraxetan, tefibazumab, tocilizumab, ustekinumab, visilizumab, votumumab, zalutumumab, and zanolimumab.
Exemplary enzymes suitable for use herein include, but are not limited to, peroxidase, lipase, amylose, organophosphate dehydrogenase, ligases, restriction endonucleases, ribonucleases, DNA polymerases, glucose oxidase, laccase, and the like.
Additional active agents to be used herein include cell growth media, such as Dulbecco's Modified Eagle Medium, fetal bovine serum, non-essential amino acids and antibiotics; growth and morphogenic factors such as fibroblast growth factor, transforming growth factors, vascular endothelial growth factor, epidermal growth factor, platelet derived growth factor, insulin-like growth factors), bone morphogenetic growth factors, bone morphogenetic-like proteins, transforming growth factors, nerve growth factors, and related proteins (growth factors are known in the art, see, e.g., Rosen & Thies, C
In some embodiments, the active agent can also be an organism such as a bacterium, fungus, plant or animal, or a virus. Moreover, the active agent may include neurotransmitters, hormones, intracellular signal transduction agents, pharmaceutically active agents, toxic agents, agricultural chemicals, chemical toxins, biological toxins, microbes, and animal cells such as neurons, liver cells, and immune system cells. The active agents may also include therapeutic compounds, such as pharmacological materials, vitamins, sedatives, hypnotics, prostaglandins and radiopharmaceuticals.
Additional applications for the articles fabricated using the methods described herein can include photomechanical actuation, electro-optic fibers, and smart materials.
When the silk fibers of the present invention are used in the textile, medical suture materials or tissue materials, either separately or combined into a composite, stimulus can be incorporated in the aforementioned method of producing the textile medical suture materials or tissue materials. For example, chemical stimuli, mechanical stimuli, electrical stimuli, or electromagnetic stimuli can also be incorporated herein. Because the silk fiber of the invention possess light-transmission property, the silk fiber contained in the textile, medical suture materials or tissue materials can be used to transmit the optical signals that may be from the stimuli or converted from the stimuli originated from the environment (e.g., tissue, organ or cells when used as implant materials) and influence the properties of the textile, suture or tissue materials. Alternatively, silk optical fiber can be used to transmit the optical signal to the applied medium, such as cells or tissues when used as implant materials, and modulate the activities of the cells or tissues. For example, cell differentiation is known to be influenced by chemical stimuli from the environment, often produced by surrounding cells, such as secreted growth or differentiation factors, cell-cell contact, chemical gradients, and specific pH levels, to name a few. Some stimuli are experienced by more specialized types of tissues (e.g., the electrical stimulation of cardiac muscle). The application of such stimuli that may be directly or indirectly transmitted by optical signal is expected to facilitate cell differentiations.
Additionally, a controlled drug delivery system can be made available by incorporating the fabricated article into the system, for example, the drug administration and release can be controlled in a manner that precisely matches physiological needs through the external stimuli applied on the fabricated article.
In some embodiments, the fabricated article is a fiber, a foam, or a film.
In some embodiments, the method described herein can be used for fabricating a silk fiber. In some embodiments, the method for fabricating a silk fiber comprises: (i) pouring a silk fibroin solution into a mold to form a fiber; (ii) holding the mold at a temperature from about −30° C. to about 25° C. for a period of time; (iii) removing the fiber from the mold; and (iv) optionally further processing the fiber.
In some other embodiments, the method for fabricating a silk fiber comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; (iii) heating the removed geled portion to reduce its viscosity and pouring at least part of the heated geled portion into a mold; (iv) holding the mold at a temperature from about −30° C. to about 25° C. for a period of time; (v) removing the fiber from the mold; and (vi) optionally further processing the fiber.
In yet some other embodiments, the method for fabricating a silk fiber comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; (iii) pouring a non-gelated portion from step (ii) into a mold to form a fiber; (iv) holding the mold at a temperature from about −30° C. to about 25° C. for a period of time; (v) removing the fiber from the mold; and (vi) optionally further processing the fiber
In still some other embodiments, the method for fabricating a silk fiber comprises: (i) incubating a silk fibroin solution at a temperature from about −30° C. to about 25° C. for a first period of time; (ii) pouring the silk fibroin solution from step (i) into a mold to form a fiber; (iii) holding the mold at a temperature from about −30° C. to about 25° C. for a second period of time; (iv) removing the fiber from the mold; and (v) optionally further processing the fiber.
A silk fiber can be further processed by applying pressure to the fiber and drawing the fiber along its elongated axis. This drawing process can be repeated 1 to about a million times. For example, the drawing process can be repeated from 1 to about 100,000; from 1 to about 10,000; from 1 to about 5,000; from 1 to about 1,000; 1 to about 500; 1 to about 400; 1 to about 300; 1 to about 250; 1 to about 200; 1 to about 150; 1 to about 100; 1 to about 75; 1 to about 50; 1 to about 25; or 1 to about 10 times.
A fabricated silk fiber can be coated with a composition comprising a polymer, e.g., a protein, such as sericin. The coated fibers have enhanced mechanical properties.
In some embodiments, the molded article can be coated with a composition comprising a polymer. Without wising to be bound by a theory, coating the molded article with a polymer provides enhanced properties. In some embodiments, the polymer is sericin.
In some embodiments, the method described herein can be used for fabricating a silk foam. As used herein the term “foam” is intended to mean a light substance. As used herein, the term “foam” includes solid porous foams, reticulated foams, water-disintegratable foams, open-cell foams, and closed-cell foams. A foam can have a density ranging from about 1 pound per square feet (pcf) to about 3 pcf.
In some embodiments, the method for fabricating a silk foam comprises: (i) pouring a silk fibroin solution into a mold; and (ii) holding the mold at a temperature from about −30° C. to about 25° C. for a period of time.
In some other embodiments, the method for fabricating a silk foam comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; and (iii) incubating a non-gelated portion from step (ii) at a temperature from about −30° C. to about 25° C. for a period of time.
In yet some other embodiments, the method for fabricating a silk foam comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; (iii) heating the removed geled portion to reduce its viscosity and pouring the heated geled portion into a mold; and (iv) holding the mold at a temperature from about −30° C. to about 25° C. for a period of time.
In still some other embodiments, the method for fabricating a silk foam comprises: (i) incubating a silk fibroin solution at pouring a temperature from about −30° C. to about 25° C. for a first period of time; (ii) pouring the silk fibroin solution from step (i) into a mold; and (iii) holding the mold at a temperature from about −30° C. to about 25° C. for a second period of time.
A silk foam fabricated using a method described herein can have a porosity of at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, or higher. Too high porosity can yield a silk foam with lower mechanical properties. Conversely, too low a porosity can yield a silk foam with high mechanical properties but may not be able to withstand physical constraints. One of skill in the art can adjust the porosity accordingly, based on a number of factors such as, but not limited to, desired mechanical properties. As used herein, the term “porosity” is a measure of void spaces in a material and is a fraction of volume of voids over the total volume, as a percentage between 0 and 100% (or between 0 and 1). Determination of porosity is well known to a skilled artisan, e.g., using standardized techniques, such as mercury porosimetry and gas adsorption, e.g., nitrogen adsorption.
The foam can have any pore size. As used herein, the term “pore size” refers to a diameter or an effective diameter of the cross-sections of the pores. The term “pore size” can also refer to an average diameter or an average effective diameter of the cross-sections of the pores, based on the measurements of a plurality of pores. The effective diameter of a cross-section that is not circular equals the diameter of a circular cross-section that has the same cross-sectional area as that of the non-circular cross-section. In some embodiments, the pores of a foam can have a size distribution ranging from about 50 nm to about 1000 μm, from about 250 nm to about 500 μm, from about 500 nm to about 250 μm, from about 1 μm to about 200 μm, from about 10 μm to about 150 μm, or from about 50 μm to about 100 μm. In some embodiments, the silk fibroin can be swellable when the silk fibroin tube is hydrated. The sizes of the pores can then change depending on the water content in the silk fibroin. The pores can be filled with a fluid such as water or air.
The inventor have discovered that pore size of a foam can be controlled by the temperature or freezing-rate used for molding. Thus, a foam produced by method described herein can a comprise smaller pores near the outer surface of the foam and larger pores in the interior of the foam. Alternatively, or in addition, one side of the foam can comprise smaller pores and the other side can comprise larger pores. As used herein, the terms “smaller” and “larger” are used in context of each other, i.e. relative to each other.
In some embodiments, the methods described herein can be used for fabricating, silk films. As used herein the term “film” refers to an article of manufacture whose width exceeds its height. A film can be of any thickness. For example, a film fabricated using a method described herein can range in thickness from about 1 nm to about 10 cm. In some embodiments, the film can have thickness in the nanometer range, e.g., from about 1 nm to about 1000 nm, from about 25 nm to about 100 nm. In some embodiments, the film can have a thickness in the micrometer range, e.g., from about 1 μm to about 1000 μm. In some embodiments, the film can have a thickness in the millimeter range, e.g., from about 1 mm to about 1000 mm.
In some embodiments, the method for fabricating a silk film comprises: (i) coating a surface of a solid-substrate with a silk fibroin solution; and (ii) incubating the coated substrate at a temperature from about −30° C. to about 25° C. for a period of time.
In some other embodiments, the method for fabricating a silk film comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; and (iii) coating a surface of a solid substrate with a non-gelated portion from step (ii); and incubating the coated substrate at a temperature from about −30° C. to about 25° C. for a period of time.
In yet some other embodiments, the method for fabricating a silk film comprises: (i) subjecting a silk fibroin solution to a gelation process; (ii) at least partially removing a geled portion of the silk fibroin solution from the silk fibroin solution; (iii) heating the removed geled portion to reduce its viscosity and coating a surface of a solid substrate with the heated geled portion; and (iv) incubating the coated substrate at a temperature from about −30° C. to about 25° C. for a period of time.
In still some other embodiments, the method for fabricating a silk foam comprises: (i) incubating a silk fibroin solution at pouring a temperature from about −30° C. to about 25° C. for a first period of time; (ii) coating a surface of solid substrate with the silk fibroin solution from step (i); and (iii) incubating the coated substrate at a temperature from about −30° C. to about 25° C. for a period of time.
Because of their unique properties, spider dragline silks have been considered for industrial applications such as for parachutes, protective clothing, and for composite materials. Many biomedical applications, such as sutures for wounds, coatings for implants, drug carriers, and scaffolds in tissue engineering have been considered as well. A significant limitation with spider silks is the difficulty in farming spiders; their territorial and aggressive behavior limits the ability to generate large amounts of native spider silk (X., X.-X., Oian, Z.-G., Ki, C. S., Park, Y. H., Kaplan, D. L., and Lee, S. Y., Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber, Proc of the National Academy of Sciences (2010), 107, pp. 14059-14063). Regenerated silk geometries not only can be derived from silkworm cocoons, which allows for larger volumes to be created, but the material can be easily customized for specific applications; e.g., antibiotics or growth factors could be incorporated into a regenerate silk fiber to make an intriguing suture material. Some of the regenerated geometries described in this document exhibit the ability to transmit light. In combination with tremendous mechanical properties, this suggests the ability to create all-polymer composites, smart fabrics, and impressive yarns and ropes. Given the ease of creating silk-based textiles, there are a number of applications in protective material, such as for making bullet-proof vests. There is evidence that light transmittance is affected by the amount of material elongation. This can be used for load/stress monitoring application. Given the excellent outcomes from mechanical drawing and rolling of the regenerated silk fibers, many material processing modalities can be used, such as press-forming or thread rolling to create screws and other machine elements, stamping and embossing to create unusual thin geometries with controlled morphologies and surface patterns, and extruding to create various prismatic bar-like geometries.
Silk egel foam or freezer-processed silk foam can be used for various applications. Flexible, open-celled foam can be used in filling defects within the body, such as in bone (osteochondrosis) or soft tissue. The compressed foam can be packed into a defect, expanding to stay in place. The open-cell architecture can provide space for drugs, antibiotics, other materials such as hydrogels, or cells for tissue re-growth. Thin foam strips can be created to act as bandages, covering minor wounds. An egel-generated film can be fabricated which has the consistency of a highly stretchable elastic material when hydrated; the consistency of writing paper when dry. In a hydrated state, the film can be used as an in vivo wrap for a fracture or an external covering/wrap for a burn or other wound. In either a foam or film/paper-like form, the material can be used as a component in a protein-based composite material. As in more traditional foam-core composites, the foam could provide the center bulk of a structure material that could provide impressive mechanical properties, yet offer the advantages of silk material and concomitant benefits of biodegradability, biocompatibility, and the ability to contain drugs, antibiotics, growth factors, etc. In one application, the material can be incorporated in soft-bodied robots that can be used for in vivo diagnostic and therapeutic purposes. The material can be used as a biodegradable alternative to traditional foam core or non-biodegradable products, such as Styrofoam coffee cups and food containers or packaging material.
Embodiments of the various aspects described herein can be illustrated by the following numbered paragraphs.
Unless stated otherwise, or implicit from context, the following terms and phrases include the meanings provided below. Unless explicitly stated otherwise, or apparent from context, the terms and phrases below do not exclude the meaning that the term or phrase has acquired in the art to which it pertains. The definitions are provided to aid in describing particular embodiments, and are not intended to limit the claimed invention, because the scope of the invention is limited only by the claims. Further, unless otherwise required by context, singular terms shall include pluralities and plural terms shall include the singular.
As used herein the terms “comprising” or “comprises” means “including” or “includes” and are used in reference to compositions, methods, and respective component(s) thereof, that are useful to the invention, yet open to the inclusion of unspecified elements, whether useful or not.
As used herein the term “consisting essentially of” refers to those elements required for a given embodiment. The term permits the presence of additional elements that do not materially affect the basic and novel or functional characteristic(s) of that embodiment of the invention.
The term “consisting of” refers to compositions, methods, and respective components thereof as described herein, which are exclusive of any element not recited in that description of the embodiment.
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients or reaction conditions used herein should be understood as modified in all instances by the term “about.” The term “about” when used in connection with percentages may mean±5% of the value being referred to. For example, about 100 means from 95 to 105.
The singular terms “a,” “an,” and “the” include plural referents unless context clearly indicates otherwise. Similarly, the word “or” is intended to include “and” unless the context clearly indicates otherwise. Thus for example, references to “the method” includes one or more methods, and/or steps of the type described herein and/or which will become apparent to those persons skilled in the art upon reading this disclosure and so forth.
Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of this disclosure, suitable methods and materials are described herein. The abbreviation, “e.g.” is derived from the Latin exempli gratia, and is used herein to indicate a non-limiting example. Thus, the abbreviation “e.g.” is synonymous with the term “for example.”
As used herein, the term “small molecule” can refer to compounds that are “natural product-like,” however, the term “small molecule” is not limited to “natural product-like” compounds. Rather, a small molecule is typically characterized in that it contains several carbon-carbon bonds, and has a molecular weight of less than 5000 Daltons (5 kDa), preferably less than 3 kDa, still more preferably less than 2 kDa, and most preferably less than 1 kDa. In some cases it is preferred that a small molecule have a molecular weight equal to or less than 700 Daltons.
The terms “decrease”, “reduced”, “reduction”, “decrease” or “inhibit” are all used herein generally to mean a decrease by a statistically significant amount. However, for avoidance of doubt, “reduced”, “reduction” or “decrease” or “inhibit” means a decrease by at least 10% as compared to a reference level, for example a decrease by at least about 20%, or at least about 30%, or at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least about 90% or up to and including a 100% decrease (e.g. absent level as compared to a reference sample), or any decrease between 10-100% as compared to a reference level.
The terms “increased”, “increase” or “enhance” or “activate” are all used herein to generally mean an increase by a statically significant amount; for the avoidance of any doubt, the terms “increased”, “increase” or “enhance” or “activate” means an increase of at least 10% as compared to a reference level, for example an increase of at least about 20%, or at least about 30%, or at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least about 90% or up to and including a 100% increase or any increase between 10-100% as compared to a reference level, or at least about a 2-fold, or at least about a 3-fold, or at least about a 4-fold, or at least about a 5-fold or at least about a 10-fold increase, or any increase between 2-fold and 10-fold or greater as compared to a reference level.
The term “statistically significant” or “significantly” refers to statistical significance and generally means at least two standard deviation (2SD) away from a reference level. The term refers to statistical evidence that there is a difference. It is defined as the probability of making a decision to reject the null hypothesis when the null hypothesis is actually true.
To the extent not already indicated, it will be understood by those of ordinary skill in the art that any one of the various embodiments herein described and illustrated can be further modified to incorporate features shown in any of the other embodiments disclosed herein.
The disclosure is further illustrated by the following examples which should not be construed as limiting. It will be apparent to those skilled in the relevant art that various modifications, additions, substitutions, and the like can be performed without altering the spirit or scope of the invention, and such modifications and variations are encompassed within the scope of the invention as defined in the claims which follow. The examples are illustrative only, and are not intended to limit, in any manner, any of the aspects described herein. The following examples do not in any way limit the invention.
The following experiments were conducted according to various embodiments of the method described herein. These experiments explored various molding strategies to generate complex silk geometries. The results of these experiments demonstrate that a variety of geometries can be created for various applications using the methods described herein. The geometries created which have a wide range of applications.
Silk electrogelation is a silk processing technique in which DC voltage is applied to a silk solution through submerged electrodes. Through the application of the DC field and resulting pH changes, the solution forms a more stable conformation with an elevation of silk I content. In this experiment, platinum electrodes and a Falcon tube were used to create gel from 8% w/v silk solution (25 VDC). After removing the gel by lifting the electrodes from the Falcon tube, the remaining silk solution was poured into a plastic Petri dish, forming a thin film. The dish was then placed in a freezer maintained at around 14° F. (−10° C.) for 8 days. After removal from the freezer, the solid film was semi-transparent with a slightly white color. The film had not contracted and still covered the bottom of the Petri dish. A razor blade was used to section the film in two, as shown in
Given the moistness, softness, and coolness of the silk egel films after removal from freezing temperatures, the films can work well in wound covering. Accordingly, two strips of egel film were placed on a hand (
A strip of egel film was soaked in a Falcon tube containing milli-Q water. After 24 hours, the film was removed by hand (
Molds of machine screws and nuts were fabricated using DragonSkin, a platinum-cured silicone rubber from Smooth-on, Inc. The two-part silicone mix was poured into plastic dishes containing five steel machine nuts and two machine screws (
Using the same molding procedure outlined in Experiment 4 above, gears molds were fabricated by embedding two plastic spur gears and a plastic worm gear in platinum-cured DragonSkin silicone. After curing the silicone containing the screws in a 60° C. oven for two hours, the plastic gears were removed. Silk solution of approximately 20% w/v concentration was poured into the screw mold cavities. The molds were then stored at 5° C. in a laboratory refrigerator for about 7 days. As in Experiment 4, the material was removed from the mold while still somewhat wet, and had a rubbery consistency. After drying, the gears were observed to be stiff and brittle.
Platinum-cured DragonSkin silicone molds of machine screws and nuts were once again created (and re-used from Experiment 4 above). Molded silk screws and nuts were produced using a higher concentration of silk solution than in Experiments 4 and 5 above. Using a concentration of approximately 30% w/v silk solution, the nuts and screws shown in
7. Molding of 8% w/v Silk Solution with Hot Egel
Silk electrogelation, as discussed above, allows the rapid conversion of a silk solution to a meta-stable gel-phase using the direct application of DC voltage through the use of electrodes. In this experiment, molded silk screws and nuts were fabricated using electrogelated silk. Silk egel was formed in a simple test cell that consisted of a Falcon tube containing several ml of 8% w/v silk solution and two vertical platinum electrodes connected to a DC power supply. A volume of silk egel was produced by applying 25 volts DC through the electrodes for 10 minutes. The egel, which forms on the positive electrode and tends to stick to the electrode, was then transferred to a plastic syringe. Because shearing action caused by extruding the egel through a syringe needle can cause the meta-stable egel to convert to a beta-sheet conformation, the egel viscosity was dramatically decreased by heating the syringe to 60-70° C. with a Wagner heat gun. When egel is heated in this way, the viscosity decreases, but the original material properties return when the egel cools back to room temperature. The hot egel was ejected from the syringe into a platinum-cured DragonSkin silicone mold (
Platinum-cured DragonSkin silicone molds of plastic gears were used from Experiment 5. Molded silk spur and worm gears were produced using a very high concentration of silk solution. Using a concentration of approximately 45% w/v silk solution (which is very challenging to measure properly become of the extreme viscosity of silk solution at this concentration), the nuts and screws shown in
A major research focus in the Tufts University Advanced Technology Laboratory has been the development of soft robots. The Tufts approach has been to create biomimetic robots that copy aspects of the Tobacco Hornworm caterpillar (manduca sexta). Therefore, robot bodies have been fabricated that mimic the general size, shape, and flexibility of a caterpillar. One long-term goal is to be able to create a completely biodegradable robot that have a better impact on the environment, allow clandestine operation, or operate within a human or animal body without need for extraction. Given this context, a silk body was fabricated using the silk molding strategies discussed above. As shown in
Silk solution made from Taiwanese cocoons was concentrated to ˜25% w/v. The silk was injected into a small diameter Tygon tube using a plastic syringe with a needle. The tube was stored in a freezer for 1-2 weeks at −5° C. Upon removal from the freezer, the molded material was removed from the tube by flushing the inner diameter with milli-Q water ejected from a syringe. The silk material was white in color, was stretchable, with the general consistency of boiled spaghetti. The ends of the fiber sample were clamped in Vise Grip clamps, providing slight tension. Before the fiber was allowed to dry, it was hand-drawn by dragging the thumb and forefinger of one hand down the length of the fiber while lateral pressure was applied by the two fingers. The fiber elongated during multiple drawing cycles, leading to a contraction in the diameter of the fiber (
Based on the success of Experiment 10, more fibers were created by molding. Fresh silk solution (solution had been created from cocoon silk within 2 days of the experiment) was used. The process can be described in 5 steps, as shown in
The molded fibers were fairly robust after the initial stretch. It was noticed that the fibers would tend to be brittle as they dried out after removal from the clamps/wrenches. After several hundreds of drawing cycles were performed, the fibers seemed to become tougher (less brittle) and stronger.
Molded regenerated silk fibers were observed to be fairly stiff and strong. To demonstrate these good material properties, a small ukulele was constructed by gluing together laser-cut acrylic pieces on a Trotec Speedy 300 laser engraver. A molded fiber, shown in
Sericin is a protein that coats the silk fibroin that makes up silkworm cocoon silk. Sericin is a glue-like substance that is important in keeping silk fiber in the shape of a cocoon. The protein is also thought to improve the toughness of silk fibers. In this experiment, a dilute Sericin (unknown concentration), provided by Pentapharm, Inc., was used to treat molded regenerated silk fibers. After fabrication of the fibers (molding in a Tygon tube and stored at approximately −6° C. for two weeks, as in Experiment 11; then suspended to dry out), they were soaked in the Sericin solution for 2 days. After removal, an Instron 3366 universal testing machine was used to compare flexural properties for untreated and Sericin-treated fibers.
Given the Sericin-treated fiber sample did not fail under flexural loading, standard tensile tests were performed to provide a more complete set of material responses for comparison.
Regenerated silkworm silk fibers were produced from silk solution that was processed 3.5 months prior and nearing self-assembly. The silk was processed from Japanese cocoons using a standard solution processing protocol (Plaza, G. R., Corsini, P., Perez-Rigueiro, J., Marsano, E., Guinea, G., and Elices, M., Effect of Water on Bombyx mori Regenerated Silk Fibers and Its Application in Modifying Their Mechanical Properties, J of Applied Polymer Science (2008), 109, pp. 1793-1801), with two modifications. The degumming (boiling) time of the cocoons was set to 60 minutes and an experimental Tangential Flow Filtration (TFF) strategy was used for dialysis. This older solution is identified in this document as “old silk”. As is typical for silk solution processed in the lab, the silk solution had been stored in a lab refrigerator at approximately 5° C. This storage temperature is used because self-assembly is slowed, providing a longer useful lifespan of the silk solution. The old silk solution was more viscous than fresher solution and had a yellowish, transparent appearance (as solution ages in the 5° C. storage environment, the initial cloudy, yellow-white coloration changes to a more transparent yellow coloration). As shown in
When regenerated silk fibers are fabricated from either “old silk” or freezer-processed silk, they exhibit a certain amount of stretchiness. After drawing cycles are applied to such fibers, some moisture is drawn out (typically, drawing has been performed using lateral finger pressure on the silk) by skin contact or driven out by the mechanical manipulation of the fiber surface. The amount that each fiber can be stretched is affected by how many cycles were used and how aggressive the lateral loading was during drawing. In this experiment, a regenerated fiber was exposed to moist (steam) heat, as shown in
In the process of drawing regenerated fibers by hand, oils present in the user's fingers can play a beneficial role in maintaining moisture in the fibers during drawing. Moisture can lead to partial plasticizing of the silk, improving the mechanical workability of the silk. To better take advantage of in a process improvement, an experiment was conducted. Molded regenerated fibers (“old silk” fibers) were first placed in boiling water for 1 minute, then air dried for 3 minutes. The fibers were then soaked in mineral oil before drawing cycles were applied (
Mechanical characterization experiments on fibers were performed on an Instron 3366 universal testing machine with Instron's Bluehill software. “Old silk” fiber samples were prepared using the protocol described in Experiment 14 and “Freezer silk” fiber samples were prepared using the freezer-processing approach described in Experiment 11. Approximately 100 mm long samples were cut with scissors. Cynoacrylate glue (Loctite 406 instant adhesive) was used to glue each fiber end to a cardboard tab (approximately 15 mm×20 mm). Another pair of cardboard tabs was glued onto the first tabs, sandwiching the fiber between, as shown in
One set of samples fabricated from the freezer-processes silk. Designated “Fr,” these fibers had been hand-drawn with greater than 700 drawing cycles. A total of 20 room temperature-processed samples created from old silk were tested. Four samples each were tested in these conditions: as-removed from the tube mold (“Old-0”); after the single stretch in the clamps (“Old-1”); after 200 drawing cycles (“Old-200”); after 400 drawing cycles (“Old-400); and after 700 drawing cycles (“Old-700”).
Using Instron's Bluehill software, a custom test method was created. Using extension control, the tests were conducted by stretching each sample at 0.2 mm/minute until fiber failure. Each initial fiber length was determined by measuring the exposed fiber length between the cardboard tabs. Fiber cross-sections were determined by first sectioning a short length of fiber adjacent to the fiber segment used in each sample. The sections were mounted and imaged using an inverted microscope. NIH's ImageJ software was used to determine the cross-sectional area. For reporting purposes, the cross-sectional areas were converted into an average diameter using the equation: Area=π*diameter2/4.
The final set of data generated in fiber testing is the Elongation to Failure (
After all fibers were tested, digital images were taken of the separated fiber fragments (not shown). Of particular note was the sample identified as “Fr 3.” This was the unique fiber sample that stretched to approximately 66% elongation before failure. This fiber developed a strikingly opaque, white appearance and was noticeably smaller in diameter than the other failed fibers (data not shown).
The rubbery nature of fibers created from regenerated silk and molded at −6° C. provides promise that traditional mechanical processing techniques can generate unique silk geometries with very attractive mechanical properties. In this experiment, a rolling process was utilized to generate a flattened silk strip. Starting with freezer-processed silk molded in the shape of a fiber, a hardened steel roller (
The microstructure of fresh silk solution is dominated by random coil molecular conformation. It is known that the conformation can become more crystalline, achieving a higher-order conformation through several methods: time-driven self assembly, increased temperature, decreased pH, through addition of ions, shearing, and several other ways. The most crystalline state, beta-sheet rich Silk II, should provide robust mechanical strength performance, with limited elongation. Silk I conformations are typically meta-stable phases in that the material can be driven to either a more random conformation or to a more stable conformation, such as a beta-sheet conformation. Given the meta-stable behavior, significant elongation is possible, and although the mechanical strength characteristics in the silk I conformation is limited, properties may increase dramatically with elongation.
Old Silk Fibers:
When old solution is examined, it typically is more viscous and has a different appearance from fresh silk solution. In brief, very fresh solution can be slightly cloudy, possibly due to bubbles. Over time, the solution can become clearer, while a yellow tint can become more pronounced. Interestingly, very old solution can be quite transparent, which is counterintuitive because one expects that an assembly process has already begun, which includes micro-crystallinity and micelle formation. In the case of the “old silk” used in this study, self-assembly can have begun, with an elevation of beta-sheet content. By molding the silk in a small, enclosed tube and leaving at room temperature for several days, the assembly process is accelerated. The material is removed from the tube before the silk is completely solid, producing a rubbery material that has high water content. Given that the material can be easily stretched, the conformation is not completely dominated by beta sheets. If the material is simply allowed to dry out, the material exhibits extremely brittle behavior. This behavior is also seen in a simple fiber formed by drawing a fiber out of a pool of concentrated silk. Water is present as bound water (strong hydrogen bonds with silk fibroin) and free water in silk solution. Fast drying of the free water can isolate silk fibroin, producing poor mechanical (brittle) performance if no significant alignment or structural organization is present.
The act of stretching the rubbery “old silk” fiber causes molecular chain alignment, with chains moving closer to one another as the fiber diameter decreases. The lack of significant beta sheet content in the rubbery material and the presence of some water ensure some mobility of the molecular chains. With closer proximity of the molecular chains, new bonds can form, producing a stronger material. As drawing cycles are applied to the material, especially in consideration of the later force being applied, water is drawn out and chains are further elongated and driven to closer proximity. This leads to observations of higher strength, to a point. The “old silk” fibers that were processed with 700 drawing cycles dropped in strength and showed dramatically less elongation to failure. It appears that the stretching of the chains and perhaps the dehydration led to damage initiation. Another consideration is that the old silk likely had some beta sheet content before molding, along with additional beta sheet formation with shearing. It is possible that the stretching of more amorphous regions among the beta sheet content reaches a limit and that in conjunction with stress concentration developed between more crystalline and non-crystalline material contents leads to premature failure for higher numbers of drawing cycles.
Freezer-Processed Fibers:
The fiber processing technique that uses sub-zero temperature gives superior mechanical performance results to the “old silk” fiber process. Starting with fresh silk solution, molded fibers are stored in a freezer set to −6° C. Li et al. (Study on Porous Silk Fibroin Materials. I. Fine Structure of Freeze Dried Silk Fibroin, J of Applied Polymer Science (2001), 79, pp. 2185-2191) reported that the initial melting temperature of the ice in frozen solution is about −8.5° C. They attributed this observation to the amino acid polar side groups that have a strong affinity to water (and lower steam pressure compared with pure ice). In their freeze-drying experiments, a significant level of silk I conformation was seen in silk fibroin that was freeze dried between −16 and −4° C. A higher level of crystallinity was seen at lower temperatures and with higher concentration silk fibroin at the same given temperature range. For silk solution frozen between −20 and −8.5° C., the removal of ice makes the silk fibroin in random-coil structure concentrated. Spatial distance between molecular chains decreases, so there's a higher level of chain interaction. In addition, molecular heat kinetic energy enables chain segments to actively move, potentially forming an ordered structure.
As discussed above herein, the freezer temperature was seen to fluctuate about the set-point (actual range likely −8 to −3° C.). While the water in silk fibroin was not completely frozen, because a rubbery, stretchable solid was formed, some elevation of silk I content can be achieved and molecular chain interaction is present in the semi-frozen material. Without wishing to be bound by a theory, using a temperature just above freezing avoids the water crystallization that can affect any assembled silk structures due to expansion. The silk I content is a meta-stable phase that can be readily stretched and relatively easily driven to a more stable phase with mechanical manipulation.
An embodiment of fabricating a molded fiber with drawing is shown in
Spongy scaffolds are frequently applied in tissue engineering for a number of reasons. A key reason is the network of pores is advantageous for allowing cell attachment, yet allowing nutrient and waste flows. In a popular approach to producing silk-based spongy scaffolds, salt leaching involves the packing of salt with controlled particle size into a mold. Silk solution is poured onto the salt, which quickly leads to self assembly of the solution. Once a gel has formed, the salt is dissolved, leaving an interconnected network of controlled pores. While the desired internal pore structure is produced, the resulting material leaves room for improvement in terms of geometric stability, ability to created three-dimensional geometries, and mechanical properties.
Inventors have discovered alternative strategies for making silk foams. One approach begins with a gel form of silk, known as electrogelated silk. Silk electrogelation involves the conversion of solubilized silk into a sticky gel through the application of DC voltage applied directly to the solution using electrodes. When the voltage is turned off, the gel can be removed from the remaining silk solution by extracting the positive electrode from the solution. It has been visually observed that the silk solution surrounding the forming gel is affected by the electrogelation process. However, the solution does not appear to form a solid material and is not removed when the gel is removed. When the solution remaining behind after electrogelation is placed in a freezer for an extended period and brought to room temperature, a range of material forms can be generated, from a bulk foam to a thin, paper-like film. This new material has features that can be exploited in various applications.
A second approach for making silk foams comprises freezer-processing of silk solution directly. After silk cocoons have been processed into a silk solution, the solution is typically stored in a refrigerator typically set to 5° C. This low temperature slows the self-assembly process within the polymer, extending the useful life of the silk solution. An interesting observation was made when a batch of silk solution was unintentionally stored overnight at a temperature of approximately −5° C. The material appeared to have self-assembled, but had a different consistency from a typical silk gel. The material had the consistency of tiramisu and could be stretched considerably. Further controlled tests have shown that freezing silk solution at a temperature range of between −5° C. to −10° C. is useful for making various silk material forms, such as fibers or robust foams. This document describes a series of experiments that were conducted using the two aforementioned silk foam fabrication techniques.
The following describes experiments conducted to explore embodiments of the method described herein for fabrication of silk foams and thin, paper-like geometries. The results of these experiments demonstrate that a variety of foam and paper-like geometries can be created which have a wide range of applications.
Silk electrogelation involves the application of a DC voltage using electrodes submerged in a solubilized silk solution to form a metastable silk gel. Prior experiments have shown that so-called “egel” exhibits unique capabilities from other silk gels. At the conclusion of an experiment that used electrogelated (egel) silk, an observation was made concerning the formation of silk foam. Using a traditional egel setup, two platinum electrodes were suspended in an 8% w/v silk solution contained in a shortened Falcon tube and 25 VDC was applied. After gel formed on the positive electrode, the egel was removed and fresh silk solution was added to allow repeated electrogelation. After multiple egel runs, the remaining silk solution, still in the Falcon tube, was placed in an EdgeStar Model FP430 thermoelectric cooler maintained at around 14° F. (−10° C.) for 6 days. The silk was removed from the cooler and kept in ambient conditions at room temperature for approximately 10 days. During this time, the sample had formed into a solid material and had shrunk approximately 25% from the Falcon tube geometry.
The resulting foam was white in color, except for a yellowed portion at the top, where the sample can have dried first (the surface of the silk solution near the top of the Falcon tube container is exposed to the experimental environment). The foam was very light and highly porous, with many small pores, resembling an open-cell foam. The outer surface was very smooth, reflecting the smooth inner surface of the Falcon tube.
To develop a deeper understanding of how sub-zero temperatures can affect foam formation using silk egel, a thin-layered construct was created. As in Experiment 1 above, a standard egel setup was used. After silk egel was formed, the remaining solution that was not part of the visible gel was separated and poured into a Petri dish. Only a thin layer of liquid silk was poured. The dish was placed in a freezer maintained at around 14° F. (−10° C.). After 3 days (
A cast acrylic material was etched with words on a Trotec laser etching machine. This material was then used as a casting substrate for silk egel foam. Approximately 8% w/v non-gelated egel solution (remaining solution from an electrogelation pool) was poured onto the acrylic with a syringe, with care taken to completely cover the acrylic without spill-over. The substrate with silk solution was then stored in a freezer maintained at approximately 14° F. (−10° C.) for 12 days. After removal from the freezer, the material was brought to room temperature and removed from the acrylic substrate, as shown in
Using the same batch of 8% w/v non-gelated egel solution from experiment 4, a large plastic tray and a plastic Petri dish were used to cast foam sheets. As shown in
Cast egel foam was created by pouring 8% w/v non-gelated egel solution into two plastic Petri dishes and placing the dishes in a freezer at 14° F. (−10° C.). After 8 days in the freezer, one dish was removed and brought to room temperature (left side in
7. Paper using Egel from High Concentration Silk
Using a traditional egel setup, two platinum electrodes were suspended in high concentration silk solution (above 20% w/v) contained in a shortened Falcon tube and 25 VDC was applied. In this experiment, after gelation, the egel was removed from the solution and placed in a plastic syringe. The syringe was heated with a heat gun to above 60° C. The heated egel was then cast in a plastic Petri dish and placed into a freezer at 14° F. (−10° C.). Note that this experiment was performed with the metastable egel material itself, in contrast to the prior experiments. After 10 days in the freezer, the silk material was inspected using a stereomicroscope, as shown in
8. Foam Construct from Remaining Egel Solution
The fabrication of much thicker foam constructs was pursued using similar silk processing conditions as in the prior experiments. Silk solution remaining after an electrogelation process was poured into a plastic cup and stored over 2 weeks in a −10° C. freezer. Within a day of storing in the freezer, an opaque, white solid was observed to form, starting from the outside diameter of the silk solution. After 2 weeks in the freezer, the sample was removed, allowed to heat to room temperature, and then sectioned using a razor blade (the sample was still hydrated in the middle). As shown in
A standard silk solution was formed using Taiwanese cocoons (
A similar experimental setup was used as in Experiment 9 above, with the exception of the cocoon source. Two cocoon sources were compared: Japanese and Chinese-supplied silk cocoons with a 30 minute degumming time. Each silk solution (between 7-8% w/v concentration) was mixed with a fine silk powder purchased from a beauty products supplier (TKB Trading) and poured into a 60 ml plastic syringe (
To explore the ability of silk foams created in this experiment to be compressed and re-expanded through hydration, a simple test was conducted. The silk construct fabricated using silk cocoons from a Chinese supplier was allow to fully dry in ambient conditions. A short segment was sectioned (
11. Silk Material Formed with a Large Volume of Silk Powder
As a further investigation of the use of silk powder, a large volume of fine silk powder (TKB Trading) was added to silk solution manufactured from Chinese cocoon silk. Upon mixing in the powder, the viscous silk solution appeared to convert to a gel, indicative of the formation of a secondary structure. The gel-like silk was dried at ambient conditions, providing a very tough material. As
In silk solution preparation, an early boiling step is used to remove the sericin protein coating that the silkworm produces on the surface of the cocoon fiber; a process known as degumming. A series of tests with silk solution derived from silk fibroin (various suppliers) was conducted to see what effect degumming time had on the ability to form quality foam. It was determined that degumming times of 30 minutes or greater makes it difficult to form a foam. In general, the higher the degumming time, the longer it takes to convert the silk solution to solid foam using the freezing process describe previously. The inventors discovered that silk powder can be used to assist in the formation of foams, despite using a 60 minute degummed silk solution. The general method included four steps: (1) 60 minute-degummed Japanese silk solution was heated in a beaker with a heating plate set to about 60 C; (2) silk powder (TKB Trading) was mixed in and the solution was then poured into a plastic syringe; (3) as shown in
Silk solution that was produced using Taiwanese cocoons and 60 minutes of boiling time (for degumming) was concentrated to about 25% w/v. The solution was heated to above 60° C., the temperature above which water bound to silk fibroin at the molecular level becomes unbound. Pure silk powder (TKB Trading) was mixed into the hot solution in a Falcon tube. After the solution was allowed to return to room temperature, the material was then poured into a plastic syringe and stored in a freezer at −5° C. After 10-14 days, the sample was removed by cutting apart the syringe body. The fully hydrated sample was air-dried at room temperature for 3-5 days. The resulting material was very hard and tough and could be machined using standard machine tools.
As in Experiment 13 above, silk solution that was produced using Taiwanese cocoons and 60 minutes of boiling time (for degumming) and concentrated to about 25% w/v. The solution was heated to above 60° C., the temperature above which water bound to silk fibroin at the molecular level becomes unbound. Pure silk powder (TKB Trading) was mixed into the hot solution in a Falcon tube. After the solution was allowed to return to room temperature, liquid nitrogen was carefully added to the solution (
As in Experiment 14 above, silk solution that was produced using Taiwanese cocoons and 60 minutes of boiling time (for degumming) was concentrated to about 25% w/v. The solution was heated to above 60° C. and silk powder (TKB Trading) was mixed into the hot solution in a Falcon tube. In contrast to Experiment 14, the warm solution with powder embedded was poured into an enclosed bone mold without the use of liquid nitrogen. The mold containing silk solution was placed in a freezer at −5° C. for about two weeks. After removal from the freezer, the mold was disassembled and the silk construct allowed to dry at ambient conditions. The resulting bone model was remarkable in the level of detail replicated in the silk. The bone model was fairly stiff, although the level of brittleness was not tested.
The thermoelectric cooler/freezer used in these foam experiments is known to exhibit some temperature swings. This is expected in all freezers, given the need to maintain a temperature target range through the use of built-in sensors and a controlled cooling device. In the case of the thermoelectric cooler, it was thought that temperature cycling within the device might be contributing to the foam formation and not just the average temperature value. To help modulate the temperature swings inside the cooler, a large beaker of water with ethylene glycol was placed inside for all experiments using the cooler. The thermal mass of the water slows the response time of the temperature swings. Because of the ethylene glycol, the water could not freeze at the sub-zero temperatures inside. To characterize the temperature profile within the cooler and to understand the nature of its temperature cycling, four thermocouples were mounted inside: one mounted to an inner wall, one on a shelf inside, one on the edge of the self, and one on the beaker that contained the water. The thermocouples were attached to a National Instruments CompactDAQ modular data acquisition chassis and temperature values were recorded with a National Instruments LabVIEW program. As seen in
In a follow-up characterization, a Tygon tube was placed across the middle of the thermoelectric cooler, spanning the beaker and the internal shelf. Four thermocouples were used to characterize the temperature: two placed inside the very ends of the Tygon tube, one on the edge of the internal cooler shelf, and one on the beaker of water. The temperature within the ends of the tube, shown in
To develop a better understanding of the mechanisms involved in forming silk foam, a series of controlled tests were conducted. In this experiment, a silk solution made from cocoons from a Chinese supplier and degummed for 30 minutes was used. The silk was poured into a Petri dish and placed in a freezer at −10° C. for 3-4 days. Once removed from the freezer, the silk (still within the dish) was transferred to a VirTis Genesis Lyophilizer (Model 25L Genesis SQ Super XL-70), in which a high vacuum was established. After the material was visibly dry (−3-4 days), it was removed from the lyophilizer. A lyophilizer helps eliminate free water in a silk solution through sublimation. In the typical usage, the sample is first flash-frozen in liquid nitrogen and placed in the vacuum. In the case of the silk foams described in this document, no flash freezing was used. The goal was to allow the free water and any bound water to be sublimated. The vacuum reduces atmospheric pressure around the sample, which then leads to a lower boiling temperature of the silk solution. As vaporization of water molecules occurs, heat is removed from the solution, which leads to freezing. The rate of water loss then slows.
Without wishing to be bound by a theory, several phenomena can help explain the morphology seen in this foam. Silk fibroin is a block copolymer that can exhibit both hydrophobic and hydrophilic behavior. This interaction can cause silk fibroin to align at a water-air interface, causing chain alignment and strong intermolecular bonds to form. This is one factor in the fine-pore structure made of dense silk fibroin that forms at the exposed upper foam surface. In addition, due to hydrophobic interactions with water, as the freezing temperature of water in silk fibroin is approached, the silk coagulates into regions of high silk concentration (a process known as freeze-concentrating). Since silk can be exhibiting a relatively low surface tension, as the water starts to freeze and expand, the silk fibroin chains stretch and align. Due to close proximity and higher mobility of the silk fibroin (which is not frozen), hydrogen bonds can form, creating pore walls. Buoyancy effects which cause water to pool at the bottom of the Petri dish and the mobility of the silk fibroin may lead to the larger pore formation in the bulk of the sample. Temperature cycling, from a temperature close to the freezing temperature of water in silk fibroin to a lower temperature, can assist in the mobility of the silk fibroin in the bulk of the sample.
Given the highly porous nature of the silk foams created in prior experiments, it was desired to determine how well relatively thin silk foam could thermally insulate objects. A resistance-based heating plot was set to a high temperature and a silk foam construct (shown in Experiment 17) was placed on top. A Fluke infrared camera was used to monitor the temperature profiles of the heating plate and silk foam over about 1 minute. As shown in
Given the ability for a silk foam to act as a thermal insulator, use of silk as an alternative to Styrofoam studied. Silk solution made with Chinese silkworm cocoons and 20 minutes of boiling time was used (−7% w/v concentration). A mold was created using DragonSkin, a platinum-cured elastomeric material from Smooth-On Corp. The two-part elastomer was mixed together and poured into a glass beaker. A take-out Styrofoam coffee cup was then pushed into the uncured elastomer to act as a positive. The inside of the coffee cup was filled with additional uncured elastomer. After storing in an over for about 2 hours to cure the elastomer, the DragonSkin mold was separated and the Styrofoam cup removed. The mold was then reassembled and the silk solution poured into the coffee cup-shaped cavity. The mold was then stored in a freezer at −10° C. for 3 days, before being transferred to a lyophilizer. After removal from the vacuum environment (−4 days), the mold was separated.
To further explore the control of porosity, as in Experiments 8 and 17, a follow-up experiment was conducted. Using the same conditions from Experiment 17 (Chinese cocoons, 30 minute degumming), a thin layer of silk solution (around 2 mm thickness) was stored in a Petri dish at −10° C. for 3-4 days, then vacuum-dried in a lyophilizer. The resulting silk foam formed a fine, interconnected-pore structure through the entire thickness (
As demonstrated in Experiment 19, silk foam can be molded into the shape of everyday objects. To explore the level of geometric complexity that is achievable, a silk foam skull was created. Starting with a Chinese cocoon source, ˜7% w/v silk solution was created using a 20 minute degumming time. A small plastic skull was obtained to act as a mold positive. The skull was suspended in a 1 liter cup, ensuring the skull did not contact the cup walls or base. A two-part, platinum-cured elastomeric material, known as DragonSkin (Smooth-on, Inc.), was poured into the space around the skull. After storing in an oven at 60° C. for two hours, the cured DragonSkin was removed from the cup. After cutting the molded DragonSkin in half (
This experiment was conducted to explore the ability for silk powder to enhance the processing of foams using the freezing process described previously. Using a Chinese cocoon source and 20 minutes of degumming time, a 7% w/v silk solution was processed. Pure silk powder (TKB Trading) was mixed into the silk solution in a Falcon tube and transferred into a plastic syringe. The syringe was stored in an EdgeStar Model FP430 thermoelectric cooler for about 4 days at −10° C. After removal from the syringe, the silk was observed to be semi-frozen and flexible. The construct was then stored in a lyophilizer for only 2 days. After entrapped water had been removed by the lyophilizer, the silk exhibited a fine-pore foam-like structure (
Overall, the freezer-processed silk foams exhibited good mechanical performance, controllable pore network, and excellent geometric stability and precision. These features can be used to create biomedical implant scaffolds for various applications. In one direction, the creation of soft silk foams for filling void space in soft tissue was studied. A series of hemispherical foam constructs were created to evaluate usage in such applications. In this experiment, a 7% w/v silk solution made from Chinese cocoons and 20 minute degumming was utilized. As in Experiment 21, a DragonSkin mold was created. The two-part platinum-cured elastomeric material was poured into a large Petri dish. An oversized ball was positioned in the DragoSkin to form a hemispherical cavity. After curing in an oven at 60° C. for 2 hours, the cured DragonSkin was removed from the Petri dish. Silk solution was poured into the mold and the construct stored in an EdgeStar Model FP430 thermoelectric cooler for about 3 days at −10° C. The silk hemisphere was then transferred to a lyophilizer for 3 days.
Given that the freezing-processed silk foams exhibit fine-pore structure in areas of high freezing rate, an experiment was conducted to better control freezing rate throughout a construct. As shown in
Silk concentration can influence the mechanical properties of geometries made from regenerated silk. To explore the variations in freezer-processed silk foam due to concentration, a series of simple geometries were created. Using a Chinese silk source and 10 minute degumming, silk solutions were prepared with concentrations of 1, 2, 3, 4, 5, and 6% w/v. This was achieved by creating a nominally ˜7% w/v solution and diluting with milli-Q water. Each prepared solution was poured into a Petri dish and processed using the freezer-processing approach described in Experiment 24. The completed foams are pictured in
Given the ease of producing high-quality silk foams using the freezer-processing technique described herein, an experiment was conducted to study the ability of silk to act as a foam stabilizer. Chicken eggs are used extensively in cooking. Because of high protein content, it was a goal to see if the freezer-processing technique could be used to form egg foam. In this experiment, egg yolks were separated from the egg whites of two medium-sized eggs. They were then mixed with equal proportions of a 7% w/v silk solution and poured into Petri dishes (Chinese cocoon source, 10 minute degumming time). Using the freezer-processing as described in Experiment 24, each was stored in a cooler and lyophilizer for a period of 3 days each. The resulting materials were interesting (
Experiment 26 was repeated, with the added goal of being able to build a foam-stabilized structure that could stabilize multiple, unique substances in a single overarching construct. A spherical mold was created using DragonSkin and a small ball. Following the procedure given in Experiment 21, the cured DragonSkin was parted with a razor blade. Egg yolks, separated from the egg whites, were mixed with 7% w/v silk solution (Chinese cocoon source, 10 minute degumming time) and poured into the mold. After storing in a freezer at −10° C. for 3 days, the egg yolk foam ball was removed from the mold and stored in a lyophilizer for another 3 days. An egg mold was created using DragonSkin and a raw egg. After curing and parting with a razor blade, the void was filled with an egg white/silk solution blend (7% w/v as above), with the egg yolk ball suspended in the middle. As with the egg yolk foam, the entire construct was stored at −10° C. for 3 days, removed from the DragonSkin mold, and then stored in a lyophilizer for another 3 days. The final construct was separated into two (
All patents and other publications identified in the specification and examples are expressly incorporated herein by reference for all purposes. These publications are provided solely for their disclosure prior to the filing date of the present application. Nothing in this regard should be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior invention or for any other reason. All statements as to the date or representation as to the contents of these documents is based on the information available to the applicants and does not constitute any admission as to the correctness of the dates or contents of these documents.
Although preferred embodiments have been depicted and described in detail herein, it will be apparent to those skilled in the relevant art that various modifications, additions, substitutions, and the like can be made without departing from the spirit of the invention and these are therefore considered to be within the scope of the invention as defined in the claims which follow. Further, to the extent not already indicated, it will be understood by those of ordinary skill in the art that any one of the various embodiments herein described and illustrated can be further modified to incorporate features shown in any of the other embodiments disclosed herein.
This application claims benefit under 35 U.S.C. §119(e) of the U.S. Provisional Application No. 61/477,486, filed Apr. 20, 2011, the content of which is incorporated herein by reference in its entirety
This invention was made with government support under grant no. EB002520 awarded by the National Institutes of Health. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US12/34401 | 4/20/2012 | WO | 00 | 8/29/2014 |
Number | Date | Country | |
---|---|---|---|
61477486 | Apr 2011 | US |